Clovis Oncology Inc (CLVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLVS | AMGN | GILD | VRTX | BIIB |
| Company | Clovis Oncology Inc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.0808 | 301.75 | 65.43 | 406.42 | 221.52 |
| High | 0.0977 | 302.76 | 65.84 | 409.48 | 221.98 |
| Low | 0.0766 | 299.92 | 65.16 | 394.03 | 218.15 |
| Last | 0.0812 | 301.37 | 65.97 | 408.43 | 218.13 |
| Change | -0.0048 | +1.89 | +0.43 | +5.93 | -3.29 |
| % Change | -5.58% | +0.63% | +0.66% | +1.47% | -1.49% |
| Volume | 24,516,400 | 541,237 | 863,192 | 520,451 | 159,302 |
| 20-Day Average Volume | 9,433,500 | 2,726,916 | 7,279,998 | 1,046,686 | 1,326,516 |
| Previous Close | 0.0860 | 299.48 | 65.54 | 402.50 | 221.42 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.2340 | 275.33 | 66.47 | 398.45 | 204.53 |
| 20-Day Raw Stochastic | 1.73% | 65.75% | 24.49% | 84.79% | 88.90% |
| 20-Day Relative Strength | 23.83% | 63.50% | 35.42% | 51.85% | 56.59% |
| Weighted Alpha | -91.19 | +28.78 | -19.80 | +16.55 | -27.27 |
| Today's Opinion | 100% Sell | 40% Buy | 100% Sell | 8% Buy | 56% Sell |
| Previous Opinion | 100% Sell | 24% Buy | 100% Sell | 8% Buy | 56% Sell |
| Last Month's Opinion | 100% Sell | 24% Sell | 100% Sell | 24% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -39.04% since 12/13/22 | +10.02% since 04/30/24 | +0.71% since 04/30/24 | +3.53% since 04/30/24 | +1.82% since 04/30/24 |
| Low | 0.0760 on 12/16/22 | 273.38 on 05/01/24 | 64.33 on 05/03/24 | 392.47 on 05/01/24 | 213.11 on 05/03/24 |
| High | 0.1439 on 12/14/22 | 322.60 on 05/03/24 | 65.89 on 05/01/24 | 409.48 on 05/07/24 | 222.40 on 05/06/24 |
| 1-Month | |||||
| %Chg | -76.74% since 11/18/22 | +11.65% since 04/05/24 | -5.63% since 04/05/24 | unch since 04/05/24 | +7.29% since 04/05/24 |
| Low | 0.0760 on 12/16/22 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 0.3772 on 12/01/22 | 322.60 on 05/03/24 | 69.95 on 04/09/24 | 409.48 on 05/07/24 | 222.40 on 05/06/24 |
| 3-Month | |||||
| %Chg | -92.75% since 09/20/22 | +1.87% since 02/07/24 | -11.77% since 02/07/24 | -2.96% since 02/07/24 | -9.06% since 02/07/24 |
| Low | 0.0760 on 12/16/22 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 1.3100 on 10/04/22 | 322.60 on 05/03/24 | 76.21 on 03/11/24 | 437.00 on 02/27/24 | 244.95 on 02/12/24 |
| 6-Month | |||||
| %Chg | -93.12% since 06/17/22 | +11.17% since 11/07/23 | -18.55% since 11/07/23 | +7.51% since 11/07/23 | -10.94% since 11/07/23 |
| Low | 0.0760 on 12/16/22 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 341.90 on 11/16/23 | 189.44 on 04/19/24 |
| High | 3.2500 on 07/08/22 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 268.30 on 01/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 11,770 | 160,633,888 | 81,602,352 | 104,029,752 | 32,238,088 |
| Shares Outstanding, K | 144,955 | 536,376 | 1,245,077 | 258,459 | 145,597 |
| Annual Sales | 148,760,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 9,835,600,000 |
| Annual Net Income | -264,520,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 1,161,100,000 |
| Last Quarter Sales | 30,660,000 | 7,447,000,000 | 6,686,000,000 | 2,517,700,000 | 2,290,500,000 |
| Last Quarter Net Income | -56,010,000 | -113,000,000 | -4,170,000,000 | 968,800,000 | 393,400,000 |
| 60-Month Beta | 0.24 | 0.60 | 0.22 | 0.39 | -0.01 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.39 on 11/09/22 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 4.76 on 05/06/24 | 3.67 on 04/24/24 |
| Latest Earnings Date | 11/09/22 | 05/02/24 | 04/25/24 | 05/06/24 | 04/24/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 06/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.71 | 16.07 | 29.84 | 14.50 |